Uh oh, how are the usual suspects going to explain away this:
On July 15, 2021, the Indonesian Food and Drug Monitoring Agency (BPOM) finally granted the Emergency Use Authorization for Ivermectin as the therapeutic drug to cure the Covid-19.
This was due to the country’s “worst-case scenario” epidemic at the time according to officials. The number of cases were soaring in the country and the medical authorities were desperate to control the outbreak.
After the government authorized the use of Ivermectin for COVID-19 patients and its population, the number of cases have significantly plummeted since July.
